Latest Breaking News On - Discontinues aducanumab - Page 1 : comparemela.com

From the impact of BMI on clinical features of bipolar disorder to FDA approval of the first integrated TMS system for MDD and OCD, here are highlights from the week in Psychiatric Times.

United statesKhaled bowarshiChepko danilMarina varnava adobestockChris viehbacherZerbor adobestockDrug administrationAmerican academy of sleep medicinePsychiatric timesDiscontinues aducanumabMajor depressive disorderStimguide proClinical featuresAmerican academySleep medicine